Alcon commercially launches Tryptyr (acoltremon ophthalmic solution) 0.003% for signs and symptoms of DED in the US

Vizz, the first aceclidine-based solution for presbyopia, was shown in clinical trials to improve near vision in as little as 30 minutes, with effects lasting up to 10 hours. Photo: Lenz Therapeutics. Click image to enlarge. Nearly four years after the launch of Allergan’s pilocarpine-based Vuity comes the approval of Vizz (aceclidine ophthalmic solution 1.44%), the second e